AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
171.56
-2.14 (-1.23%)
At close: Jan 17, 2025, 4:00 PM
171.60
+0.04 (0.02%)
After-hours: Jan 17, 2025, 7:12 PM EST
AbbVie Employees
AbbVie had 50,000 employees as of January 31, 2024. The number of employees did not change compared to the previous year.
Employees
50,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,110,660
Profits / Employee
$101,620
Market Cap
303.17B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jan 31, 2024 | 50,000 | 0 | - |
Jan 31, 2023 | 50,000 | 0 | - |
Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
Jan 31, 2020 | 30,000 | 0 | - |
Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
Jan 31, 2013 | 21,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ABBV News
- 1 day ago - Top 4 Immunology Stocks Poised For Growth In 2025 - Seeking Alpha
- 3 days ago - Income & Growth: 3 Of The Best Dividend Stocks For Any Market - Seeking Alpha
- 5 days ago - AbbVie Inc. (ABBV) J.P. Morgan 43rd Annual Healthcare Conference (Transcript) - Seeking Alpha
- 5 days ago - AbbVie to 'commit less capital' towards psychiatric drugs, CEO says - Reuters
- 5 days ago - My Dividend Stock Portfolio: $10,000 In Dividends In 2024 - 97 Holdings With 13 Buys - Seeking Alpha
- 5 days ago - Alzamend Neuro to Present at the Sequire Investor Summit - Business Wire
- 6 days ago - AbbVie Has Immense Cash Flow Potential - Seeking Alpha
- 7 days ago - Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha